These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23344621)

  • 41. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights.
    Janakiraman K; Krishnaswami V; Rajendran V; Natesan S; Kandasamy R
    Mater Today Commun; 2018 Dec; 17():200-213. PubMed ID: 32289062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.
    Wang H; Tam YY; Chen S; Zaifman J; van der Meel R; Ciufolini MA; Cullis PR
    Mol Ther; 2016 Dec; 24(12):2100-2108. PubMed ID: 27633442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
    Huang X; Chau Y
    Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
    Weinstein S; Toker IA; Emmanuel R; Ramishetti S; Hazan-Halevy I; Rosenblum D; Goldsmith M; Abraham A; Benjamini O; Bairey O; Raanani P; Nagler A; Lieberman J; Peer D
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E16-22. PubMed ID: 26699502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.
    Yamamoto Y; Lin PJ; Beraldi E; Zhang F; Kawai Y; Leong J; Katsumi H; Fazli L; Fraser R; Cullis PR; Gleave M
    Clin Cancer Res; 2015 Nov; 21(21):4845-55. PubMed ID: 26106075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery.
    Xiao H; Altangerel A; Gerile G; Wu Y; Baigude H
    ACS Appl Mater Interfaces; 2016 Mar; 8(12):7638-45. PubMed ID: 26964858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.
    Chakraborty C
    Curr Drug Targets; 2007 Mar; 8(3):469-82. PubMed ID: 17348839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
    Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
    J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Ligand Independent Tropism of siRNA-LNP by Small Molecules for Directed Therapy of Liver or Myeloid Immune Cells.
    Lin C; Mostafa A; Jans A; Wolters JC; Mohamed MR; Van der Vorst EPC; Trautwein C; Bartneck M
    Adv Healthc Mater; 2023 Jan; ():e2202670. PubMed ID: 36617516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.
    Judge AD; Bola G; Lee AC; MacLachlan I
    Mol Ther; 2006 Mar; 13(3):494-505. PubMed ID: 16343994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A bridge to silencing: Co-assembling anionic nanoparticles of siRNA and hyaluronan sulfate via calcium ion bridges.
    Forti E; Kryukov O; Elovic E; Goldshtein M; Korin E; Margolis G; Felder S; Ruvinov E; Cohen S
    J Control Release; 2016 Jun; 232():215-27. PubMed ID: 27117458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing.
    Wu C; Li J; Wang W; Hammond PT
    ACS Nano; 2018 Jul; 12(7):6504-6514. PubMed ID: 29944833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct CNS delivery of siRNA mediates robust silencing in oligodendrocytes.
    Querbes W; Ge P; Zhang W; Fan Y; Costigan J; Charisse K; Maier M; Nechev L; Manoharan M; Kotelianski V; Sah DW
    Oligonucleotides; 2009 Mar; 19(1):23-29. PubMed ID: 19093781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
    Ramishetti S; Kedmi R; Goldsmith M; Leonard F; Sprague AG; Godin B; Gozin M; Cullis PR; Dykxhoorn DM; Peer D
    ACS Nano; 2015 Jul; 9(7):6706-16. PubMed ID: 26042619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
    Lee SJ; Lee A; Hwang SR; Park JS; Jang J; Huh MS; Jo DG; Yoon SY; Byun Y; Kim SH; Kwon IC; Youn I; Kim K
    Mol Ther; 2014 Feb; 22(2):397-408. PubMed ID: 24145554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells.
    Uemura Y; Naoi T; Kanai Y; Kobayashi K
    Pharm Dev Technol; 2019 Mar; 24(3):263-268. PubMed ID: 29688101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
    Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
    Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.